Related Experiment Video
Updated: Aug 7, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Paracoccidioidomycosis and AIDS: report of the first two Colombian cases
A M Tobon1, B Orozco, S Estrada
1Grupo de Micología, Corporación para Investigaciones Biológicas (CIB), Medellin, Colombia.
Abstract:
The records of the first two Colombian patients with AIDS and paracoccidioidomycosis are presented. Both patients were males and had no known risk factors for HIV although in the past they had worked in the field where they could have been infected with the fungus. They exhibited the juvenile type of disease with multiple organ system involvement and symptoms of short duration. They were deeply immunodepressed as indicated by less than 100 CD4 T lymphocytes per mL; however, serologic tests revealed circulating anti-Paracoccidioides brasiliensis antibodies and in one patient the first diagnostic clue came from such tests. In one case, the mycosis preceded the AIDS diagnosis while in the other, both pathologies were discovered simultaneously. Antimycotic therapy with itraconazole was administered for over 10 months, with an initial dose of 200 mg/day followed by 100 mg/day; marked improvement of the mycotic signs and symptoms was soon noticed an there have been no signs of relapse. The patients improvement was also due to the combined retroviral treatment that was instituted. In spite of the rarity of the AIDS-paracoccidioidomycosis association, physicians practicing in endemic areas should consider the presence of the mycosis in immunosuppressed patients, since a prompt diagnosis and institution of combined antimycotic-anti-retroviral treatments would result in patient improvement and survival. It appears possible that the longer survival time of today's AIDS patients would give the quiescent fungus the opportunity to revive, multiply and cause overt disease.
Insights
The first two Colombian patients with Acquired Immunodeficiency Syndrome (AIDS) and paracoccidioidomycosis showed improvement with combined antifungal and antiretroviral therapy. Early diagnosis and treatment are crucial for managing this rare co-infection in endemic areas.
Area of Science:
- Infectious Diseases
- Mycology
- Immunology
Background:
- Presents the first documented cases of Acquired Immunodeficiency Syndrome (AIDS) co-infection with paracoccidioidomycosis in Colombia.
- Highlights the challenges in diagnosing rare opportunistic infections in immunocompromised patients.
Observation:
- Two male patients with AIDS presented with juvenile-type paracoccidioidomycosis, characterized by rapid onset and multi-organ involvement.
- Patients exhibited severe immunosuppression (CD4 T cells <100/mL), yet showed positive serology for Paracoccidioides brasiliensis.
- Diagnosis timing varied, with mycosis preceding AIDS in one case and simultaneous discovery in the other.
Findings:
- Combined antimycotic therapy (itraconazole) and antiretroviral treatment led to marked improvement and no relapse in both patients.
- Serologic tests for P. brasiliensis provided an early diagnostic clue in one patient.
- Successful management underscores the importance of considering fungal infections in AIDS patients.
Implications:
- Suggests that increased survival in modern AIDS patients may allow latent fungal infections like paracoccidioidomycosis to reactivate.
- Emphasizes the need for heightened clinical suspicion of mycosis in immunosuppressed individuals in endemic regions.
- Advocates for prompt diagnosis and combined antimycotic-antiretroviral therapy to improve outcomes for this rare co-infection.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis
Cryptococcal Meningitis
American Trypanosomiasis

